Valuation: Cello Health plc

Market Cap 179M 237M 208M 196M 335M 22.7B 337M 2.35B 910M 11.59B 889M 870M 37.26B P/E 2024
43.4x
P/E 2025 -109x
Enterprise Value 179M 237M 208M 196M 335M 22.7B 337M 2.35B 910M 11.6B 889M 870M 37.27B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
-
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 51 13/08/2020
Director/Board Member 47 15/12/2023

Financials

2024 2025
Net sales - -
Net income 4.12M 5.46M 4.79M 4.53M 7.72M 523M 7.78M 54.17M 20.98M 267M 20.51M 20.06M 859M -1.64M -2.17M -1.9M -1.8M -3.06M -208M -3.08M -21.48M -8.32M -106M -8.13M -7.96M -341M
Net Debt 1.34M 1.78M 1.56M 1.47M 2.51M 170M 2.53M 17.61M 6.82M 86.94M 6.67M 6.52M 279M 42K 55.61K 48.8K 46.09K 78.62K 5.33M 79.18K 552K 214K 2.72M 209K 204K 8.75M
Logo Cello Health plc
Cello Health plc, formerly Cello Group plc, is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company provides a range of biotech, diagnostics, devices and other non-healthcare clients. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company's pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services to the Company's consumer facing clients. The Company delivers its services from office networks in the United Kingdom, the United States and Singapore.
Employees
-
Sector
-